UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VCEL — Vericel Corp
CIK 861177
NEW YORK, NY
Position in VCEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,725,722
+$506,443 QoQ
Shares Held
83,743
-16.3% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. VCEL ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,725,722 | 83,743 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,219,279 | 100,071 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,468,947 | 96,333 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,947,540 | 93,662 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,933,519 | 162,950 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,489,507 | 123,028 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $6,195,878 | 112,837 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,071,673 | 96,371 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,989,262 | 108,746 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,872,853 | 55,226 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,873,154 | 52,602 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,711,964 | 51,073 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,155,500 | 30,756 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $901,763 | 30,756 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $823,756 | 31,274 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $725,555 | 31,274 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $787,477 | 31,274 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,564,839 | 40,943 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,609,058 | 40,943 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,998,017 | 40,943 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,152,971 | 41,009 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,700,773 | 30,617 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $910,311 | 29,479 | Shares | Sole | 2021-03-01 | |
| 2020-09-30 | $709,309 | 38,279 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $537,376 | 38,884 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $454,106 | 49,521 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||